60 likes | 221 Views
Biomarker technology is evidencing increased application from key segments such as disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. Biomarkers are novel diagnostic solutions and advancement in it its development and understanding of human genome promotes its application in diagnosis of disease on molecular basis. Pharmaceutical companies which are interested in introducing novel diagnostic solution are increasing partnership and collaboration with private laboratories, educational institute and these companies are also increasing their investments in research and development. Get full report & TOC @: http://www.researchbeam.com/biomarkers-market
E N D
RESEARCH BEAM SIZE FORECAST RESEARCH DEMAND Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis) - Industry Analysis, Emerging Technologies, Competitive Intelligence, Growth Trends, Size, Share, Forecast, 2013 - 2020 AND SIZE MARKET AND & RESEARCH RESEARCH RESEARCH MARKET SIZE FORECAST RESEARCH DEMAND AND SIZE MARKET AND & RESEARCH RESEARCH • TELEPHONE: +1 (855) 711-1555E-MAIL:sales@researchbeam.com FORECAST
ReportOverview Biomarkers Market 2013-2020, Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast by Research Beam Biomarker technology is evidencing increased application from key segments such as disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. Biomarkers are novel diagnostic solutions and advancement in it its development and understanding of human genome promotes its application in diagnosis of disease on molecular basis. Pharmaceutical companies which are interested in introducing novel diagnostic solution are increasing partnership and collaboration with private laboratories, educational institute and these companies are also increasing their investments in research and development.
ReportOverview The global market for diagnostic biomarker expected to reach about $30.6 billion in 2020 growing at CAGR of 16% from 2013 to 2020. Disease diagnostic application remains the key area of application that is expected to reach 6.1 $billion in 2020. However application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly. Molecular diagnostics is expected to grow at a CAGR of 17.6% from 2013 to 2020. SCOPE Global diagnostic Biomarker report segments the market in three categories; market by technologies, market by services, and market by diseases. These markets are expected to show elevated growth in future as biomarkers are providing diagnostic service for complex disease. As it is non-invasive procedure it motivates the use of biomarkers than conventional diagnostic applications.
ReportOverview KEY DELIVERABLES Biomarkers of disease are majorly covered by oncology, cardiovascular and Neurology disease. Oncology biomarkers are covering more market share as compared to other disease biomarkers. Other biomarker are facing some ethical and technical problem such complex sample preparation process. Biomarkers in service has open a new market for sample preparation for disease diagnosis which enables clinicians to save time required for preparing sample to conduct diagnostic test. Biomarkers are also resolving drug validation problem by analyzing viability of drug discovered by pharmaceutical research. Enquire about report @: http://www.researchbeam.com/biomarkers-market/enquire-about-report
Table of Content CHAPTER 1 INTRODUCTION 1.1 Scope and Coverage 1.2 Report Description CHAPTER 2 EXECUTIVE SUMMARY 2.1 Biomarker Diagnosis Vs. Conventional Diagnosis 2.2 Why Diagnostic Biomarkers are Used in Diagnosis and Drug Development? CHAPTER 3 MARKET OVERVIEW 3.1 Key Application of Diagnostic Biomarkers in Top Technologies 3.1.1 Omics Technology 3.1.1.1 Applications of Omics Technology CHAPTER 4 GLOBAL DIAGNOSTIC BIOMARKER MARKET BY TYPES, 2013-2020, $MILLION 4.1 Biomarker of Exposure 4.2 Biomarkers of Disease
Contact Visit us at : http://www.researchbeam.com/biomarkers-market • TELEPHONE: +1 (855) 711-1555E-MAIL:help@researchbeam.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States